A detailed history of Black Rock Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,811,507 shares of GOSS stock, worth $2.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,811,507
Previous 3,089,326 8.99%
Holding current value
$2.7 Million
Previous $3.65 Million 30.59%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.51 - $1.27 $141,687 - $352,830
-277,819 Reduced 8.99%
2,811,507 $2.53 Million
Q1 2024

May 10, 2024

SELL
$0.8 - $1.51 $231,456 - $436,873
-289,320 Reduced 8.56%
3,089,326 $3.65 Million
Q4 2023

Feb 13, 2024

SELL
$0.48 - $1.08 $522,243 - $1.18 Million
-1,088,007 Reduced 24.36%
3,378,646 $3.07 Million
Q3 2023

Nov 13, 2023

BUY
$0.78 - $1.82 $1.99 Million - $4.65 Million
2,554,648 Added 133.61%
4,466,653 $3.71 Million
Q2 2023

Aug 11, 2023

SELL
$0.98 - $1.53 $2.82 Million - $4.41 Million
-2,881,674 Reduced 60.11%
1,912,005 $2.29 Million
Q1 2023

May 12, 2023

SELL
$0.96 - $2.92 $594,570 - $1.81 Million
-619,344 Reduced 11.44%
4,793,679 $6.04 Million
Q4 2022

Feb 13, 2023

SELL
$1.74 - $12.87 $165,567 - $1.22 Million
-95,154 Reduced 1.73%
5,413,023 $11.7 Million
Q3 2022

Nov 14, 2022

BUY
$7.21 - $14.88 $2.47 Million - $5.09 Million
342,213 Added 6.62%
5,508,177 $66 Million
Q2 2022

Aug 12, 2022

SELL
$5.97 - $9.97 $974,106 - $1.63 Million
-163,167 Reduced 3.06%
5,165,964 $43.2 Million
Q1 2022

May 12, 2022

SELL
$8.44 - $12.49 $848,684 - $1.26 Million
-100,555 Reduced 1.85%
5,329,131 $46.3 Million
Q4 2021

Feb 10, 2022

BUY
$10.12 - $14.07 $676,177 - $940,101
66,816 Added 1.25%
5,429,686 $61.4 Million
Q3 2021

Nov 09, 2021

SELL
$7.25 - $13.23 $383,778 - $700,330
-52,935 Reduced 0.98%
5,362,870 $67.4 Million
Q2 2021

Aug 11, 2021

BUY
$8.0 - $9.75 $43.3 Million - $52.8 Million
5,415,805 New
5,415,805 $44 Million

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $90.2M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.